1-1387227-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_030937.6(CCNL2):c.*4G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,596,080 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0088 ( 23 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 25 hom. )
Consequence
CCNL2
NM_030937.6 3_prime_UTR
NM_030937.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.329
Genes affected
CCNL2 (HGNC:20570): (cyclin L2) The protein encoded by this gene belongs to the cyclin family. Through its interaction with several proteins, such as RNA polymerase II, splicing factors, and cyclin-dependent kinases, this protein functions as a regulator of the pre-mRNA splicing process, as well as in inducing apoptosis by modulating the expression of apoptotic and antiapoptotic proteins. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-1387227-C-T is Benign according to our data. Variant chr1-1387227-C-T is described in ClinVar as [Benign]. Clinvar id is 3043139.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00875 (1334/152386) while in subpopulation AFR AF= 0.029 (1205/41588). AF 95% confidence interval is 0.0276. There are 23 homozygotes in gnomad4. There are 655 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 23 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCNL2 | NM_030937.6 | c.*4G>A | 3_prime_UTR_variant | 11/11 | ENST00000400809.8 | NP_112199.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCNL2 | ENST00000400809 | c.*4G>A | 3_prime_UTR_variant | 11/11 | 1 | NM_030937.6 | ENSP00000383611.3 |
Frequencies
GnomAD3 genomes AF: 0.00871 AC: 1326AN: 152268Hom.: 23 Cov.: 33
GnomAD3 genomes
AF:
AC:
1326
AN:
152268
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00292 AC: 707AN: 242042Hom.: 8 AF XY: 0.00231 AC XY: 303AN XY: 131334
GnomAD3 exomes
AF:
AC:
707
AN:
242042
Hom.:
AF XY:
AC XY:
303
AN XY:
131334
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00121 AC: 1752AN: 1443694Hom.: 25 Cov.: 30 AF XY: 0.00112 AC XY: 800AN XY: 716974
GnomAD4 exome
AF:
AC:
1752
AN:
1443694
Hom.:
Cov.:
30
AF XY:
AC XY:
800
AN XY:
716974
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00875 AC: 1334AN: 152386Hom.: 23 Cov.: 33 AF XY: 0.00879 AC XY: 655AN XY: 74528
GnomAD4 genome
AF:
AC:
1334
AN:
152386
Hom.:
Cov.:
33
AF XY:
AC XY:
655
AN XY:
74528
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CCNL2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at